Vaccine

Induction of cellular immunity to a mycobacterial antigen adsorbed on lamellar particles of lactide polymers
pp. 1814-1819(6)
Authors: Venkataprasad N.; Coombes A.G.A.; Singh M.; Rohde M.; Wilkinson K.; Hudecz F.; Davis S.S.; Vordermeier H.M.

Susceptibility to tetanus and missed vaccination opportunities in Portuguese women
pp. 1820-1825(6)
Authors: Goncalves G.; Santos M.A.; Cutts F.T.; Barros H.

The effect of immunization on chemokines and CCR5 and CXCR4 coreceptor functions in SIV binding and chemotaxis
pp. 1826-1836(11)
Authors: Wang Y.; Tao L.; Mitchell E.; Bergmeier L.; Doyle C.; Lehner T.

Phase II study of anti-CD4 idiotype vaccination in HIV positive volunteers
pp. 1837-1845(9)
Authors: Schedel I.; Sutor G.-C.; Hunsmann G.; Jurkiewicz E.

Immunogenicity of peptides derived from a fibronectin-binding protein of S. aureus expressed on two different plant viruses
pp. 1846-1857(12)
Authors: Brennan F.R.; Jones T.D.; Longstaff M.; Chapman S.; Bellaby T.; Smith H.; Xu F.; Hamilton W.D.O.; Flock J.-I.

Emergency vaccination of sheep against foot-and-mouth disease: protection against disease and reduction in contact transmission
pp. 1858-1868(11)
Authors: Cox S.J.; Barnett P.V.; Dani P.; Salt J.S.

Recombinant, chimaeric live, attenuated vaccine (ChimeriVax&unknown;) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective i
pp. 1869-1882(14)
Authors: Monath T.P.; Soike K.; Levenbook I.; Zhang Z.-X.; Arroyo J.; Delagrave S.; Myers G.; Barrett A.D.T.; Shope R.E.; Ratterree M.; Chambers T.J.; Guirakhoo F.

Calcitriol (1,25-dihydroxy-vitamin D3) coadministered with influenza vaccine does not enhance humoral immunity in human volunteers
pp. 1883-1888(6)
Authors: Kriesel J.D.; Spruance J.

IgG subclass distribution of antibodies after vaccination of adults with pneumococcal conjugate vaccines
pp. 1889-1897(9)
Authors: Soininen A.; Seppala I.; Nieminen T.; Eskola J.; Kayhty H.

Reactogenicity in the elderly of nine commercial influenza vaccines: results from the Italian SVEVA
pp. 1898-1904(7)
Authors: Spila-Alegiani S.; Salmaso S.; Cristina Rota M.; Eugenio Tozzi A.; Raschetti R.

Safety of a trivalent live attenuated intranasal influenza vaccine, FluMist&unknown;, administered in addition to parenteral trivalent inactivated influenza vaccine to seniors with chronic medical conditions
pp. 1905-1909(5)
Authors: Jackson L.A.; Holmes S.J.; Mendelman P.M.; Huggins L.; Cho I.; Rhorer J.

Cell-mediated and antibody immune responses to AIK-C and Connaught monovalent measles vaccine given to 6 month old infants
pp. 1910-1918(9)
Authors: Pabst H.F.; Spady D.W.; Carson M.M.; Krezolek M.P.; Barreto L.; Wittes R.C.

Safety and immunogenicity of a new formulation of an inactivated hepatitis A vaccine
pp. 1919-1925(7)
Authors: Dagan R.; Greenberg D.; Goldenbertg-Gehtman P.; Vidor E.; Briantais P.; Pinsk V.; Athias O.; Dumas R.

A cost-benefit analysis of BCG revaccination in the Czech Republic
pp. 1926-1935(10)
Authors: Pathania V.S.; Trnka L.; Krejbich F.; Dye C.

Salbutamol as an adjuvant for nasal vaccination
pp. 1936-1941(6)
Authors: Fermin Z.; Bout D.; Ricciardi-Castagnoli P.; Hoebeke J.

Characterization of high-growth reassortant influenza A viruses generated in MDCK cells cultured in serum-free medium
pp. 1942-1950(9)
Authors: Voeten J.T.M.; Brands R.; Palache A.M.; van Scharrenburg G.J.M.; Rimmelzwaan G.F.; Osterhaus A.D.M.E.; Claas E.C.J.

Vaccine potential of a herpes simplex virus type 2 mutant deleted in the PK domain of the large subunit of ribonucleotide reductase (ICP10)
pp. 1951-1963(13)
Authors: Aurelian L.; Kokuba H.; Smith C.C.

Effects of DNA immunization formulated with bupivacaine in murine and guinea pig models of genital herpes simplex virus infection
pp. 1964-1969(6)
Authors: Bernstein D.I.; Tepe E.R.; Mester J.C.; Arnold R.L.; Stanberry L.R.; Higgins T.

Differences in the avidity of antibodies evoked by four different pneumococcal conjugate vaccines in early childhood
pp. 1970-1977(8)
Authors: Anttila M.; Eskola J.; &unknown;9hman H.; Kayhty H.

Low prevalence of diphtheria immunity in the Spanish population: results of a cross-sectional study
pp. 1978-1982(5)
Authors: Garca-Corbeira P.; Dal-Re R.; Garca-de-Lomas J.; Aguilar L.

An experimental multivalent bovine virus diarrhea virus E2 subunit vaccine and two experimental conventionally inactivated vaccines induce partial fetal protection in sheep
pp. 1983-1991(9)
Authors: Bruschke C.J.M.; van Oirschot J.T.; van Rijn P.A.

DNA immunization of mice and macaques with plasmids encoding hepatitis C virus envelope E2 protein expressed intracellularly and on the cell surface
pp. 1992-2002(11)
Authors: Forns X.; Emerson S.U.; Tobin G.J.; Mushahwar I.K.; Purcell R.H.; Bukh J.

Induction of mucosal immunity with a replication-defective adenoviral recombinant
pp. 2003-2008(6)
Authors: Xiang Z.; Ertl H.C.J.

Peptide based cytotoxic T-cell vaccines; delivery of multiple epitopes, help, memory and problems
pp. 2009-2019(11)
Authors: Elliott S.L.; Pye S.; Le T.; Mateo L.; Cox J.; Macdonald L.; Scalzo A.A.; Forbes C.A.; Suhrbier A.

Induction of immune responses in pigs following oral administration of purified F4 fimbriae
pp. 2020-2029(10)
Authors: Van den Broeck W.; Cox E.; Goddeeris B.M.

Reactogenicity of a three-dose pertussis acellular vaccine catch-up in children 21-40 months of age
pp. 2030-2035(6)
Authors: Ciofi degli Atti M.; Anemona A.; Tozzi A.E.; Stefanelli P.; Giammanco A.; Salmaso S.

Induction of mucosal IgA by a novel jet delivery technique for HIV-1 DNA
pp. 2036-2042(7)
Authors: Lundholm P.; Asakura Y.; Hinkula J.; Lucht E.; Wahren B.

Highly immunogenic and fully synthetic peptide-carrier constructs targetting GNRH
pp. 2043-2050(8)
Authors: Beekman N.J.C.M.; Schaaper W.M.M.; Turkstra J.A.; Meloen R.H.

Expression of interleukin-2 receptor and CD45RO antigen on T lymphocytes cultured with rubella virus antigen, compared with humoral immunity in rubella vaccinees
pp. 2051-2058(8)
Authors: Toyoda M.; Ihara T.; Nakano T.; Ito M.; Kamiya H.

Antigenic and immunogenic properties of inactivated polio vaccine made from Sabin strains
pp. 2059-2066(8)
Authors: Kersten G.; Hazendonk T.; Beuvery C.

Subcutaneous versus intramuscular injection for booster DT vaccination of adolescents
pp. 2067-2072(6)
Authors: Mark A.; Carlsson R.-M.; Granstrom M.

Immunization with influenza A virus hemagglutinin and neuraminidase produced in recombinant baculovirus results in a balanced and broadened immune response superior to conventional vaccine
pp. 2073-2080(8)
Author: Johansson B.E.

Epitope-specific cytotoxic T lymphocyte induction by minigene DNA immunization
pp. 2081-2088(8)
Authors: Iwasaki A.; Dela Cruz C.S.; Young A.R.; Barber B.H.

DNA inoculation with a plasmid vector carrying the faeG adhesin gene of Escherichia coli K88ab induced immune responses in mice and pigs
pp. 2089-2095(7)
Authors: Turnes C.G.; Aleixo J.A.G.; Monteiro A.V.; Dellagostin O.A.

Nasal and parenteral immunizations with diphtheria toxoid using monoglyceride/fatty acid lipid suspensions as adjuvants
pp. 2096-2103(8)
Authors: Schroder U.; Svenson S.B.

Development of a rubella virus DNA vaccine
pp. 2104-2112(9)
Authors: Pougatcheva S.O.; Abernathy E.S.; Vzorov A.N.; Compans R.W.; Frey T.K.